THE PROJECT AIMS TO DEVELOP, FORMULATE AND TEST NEW NUTRACEUTICAL, PHARMACEUTICAL AND DERMOCOSMETOLOGICAL PRODUCTS. STARTING FROM FORMULATIVE STUDIES THAT DEFINE FORMS OF DELIVERY OF THESE PRODUCTS, THE PROJECT WILL BE BASED ON TWO FUNDAMENTAL ASPECTS: 1) THE BEST AVAILABILITY OF THE ACTIVE INGREDIENTS BOTH OF NATURAL ORIGIN AND OF SYNTHESIS AND 2) THE RELATIVE REDUCTION OF THE POTENTIAL TOXIC EFFECTS FOR HUMAN LAORGANISMO THANKS TO THE FACT THAT THEY ARE NATURAL PRODUCTS AND LOW TOXICOLOGICAL IMPACT FOR HUMAN HEALTH OR NEW PHARMACEUTICAL FORMULATIONS THANKS TO WHICH IT WILL BE POSSIBLE TO USE REDUCED DOSES REDUCING THE POSSIBLE SIDE EFFECTS. IN ADDITION, A DEDICATED CLINICAL TRIAL CENTER (CTC) WILL BE BUILT THAT IS ABLE TO BRING THE PRODUCTS OF THE TRIAL TO THE REGISTRATION PHASE. THE CENTRE WILL CONSIST OF OPERATIONAL UNITS FULLY INTEGRATED FROM A FUNCTIONAL POINT OF VIEW: THE RESEARCH UNITS